Investor Relations
Headquartered near Seattle, Washington, with an office in Vancouver, BC, OncoGenex Pharmaceuticals is a drug discovery and development company uniquely focused on the challenge of cancer treatment resistance.
The Investor Relations section of our website is designed to provide you with useful resources and financial information about our company.
Investor Relations Contact
Susan W. Specht
Director, Investor Relations
Phone: 425-686-1535
Email: sspecht@oncogenex.com
Stock Quote (NASDAQ: OGXI)
Price:
12.73
Change:
+ 0.33
Volume:
90,100
4:00 PM ET on May 18, 2012
Delayed at least 20 minutes.
Provided by eSignal.
Provided by eSignal.
|
Webcasts & Presentations
|
|||
|
May 3, 2012
|
OncoGenex First Quarter 2012 Conference Call | Listen to webcast | |
|---|---|---|---|
|
Apr 20, 2012
10:30 AM ET |
Future Leaders in the Biotech Industry Conference | Listen to webcast | |
|
Apr 4, 2012
10:00 AM ET |
11th Annual Needham Healthcare Conference | Listen to webcast | |
© 2004-2011 OncoGenex Pharmaceuticals Inc. All rights reserved.
OncoGenex product candidates are investigational drugs for use only in approved clinical trials.